4th European Biosimilars Conference

As the 4th conference of its kind, the 2016 programme gives a complete 360-degree overview of biosimilar medicines. Participants will leave the conference with a wealth of new information and an expanded network of contacts.

Back to Agenda

Session 5: Pharmacovigilance continued

Session Chair(s)

Thijs Giezen, PharmD, PhD, MSc

, Medicines Evaluation Board, Netherlands

Speaker(s)

Practical Aspects and Intermediate Solutions - Hospital Experience on Traceability

Barbara Claus

Hospital Pharmacist, University Hospital Ghent, Belgium

Escher Study and Learnings Thereof

Kevin Klein, MSc

Project manager, Ligature ( Escher), Netherlands